Evidence map›Paper›PMID 19386110›Full record

ArticleBMC infectious diseases2009

Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report.

Pierre Emmanuel Charles, Emmanuel Kus, Serge Aho, Sébastien Prin, Jean-Marc Doise, Nils-Olivier Olsson, Bernard Blettery, Jean-Pierre Quenot

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02130986 (Procalcitonin Antibiotic Consensus Trial), which is not on this map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02130986 nacompletednot on this mapstarted 2014, after this paper: background citation

Procalcitonin Antibiotic Consensus Trial (ProACT)

TypeinterventionalSponsorUniversity of PittsburghRan2014 to 2017Enrolled1,664ConditionsLower Respiratory Tract Infection (LRTI)ArmsProcalcitonin level, Results of procalcitonin (PCT) level to treating clinician, Provide procalcitonin guideline to treating clinician, Telephone Visit
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Review
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Procalcitonin in acute cardiac patients.Internal and emergency medicine · 2011
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pierre Emmanuel CharlesService de Réanimation Médicale, Hôpital Le Bocage, CHU de DIJON, France. pierre-emmanuel.charles@chu-dijon.fr
Emmanuel Kus
Serge Aho
Sébastien Prin
Jean-Marc Doise
Nils-Olivier Olsson
Bernard Blettery
Jean-Pierre Quenot

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe usefulness of procalcitonin (PCT) measurement in critically ill medical patients with suspected nosocomial infection is unclear. The aim of the study was to assess PCT value for the early diagnosis of bacterial nosocomial infection in selected critically ill patients.

methodsAn observational cohort study in a 15-bed intensive care unit was performed. Seventy patients with either proven (n = 47) or clinically suspected but not confirmed (n = 23) nosocomial infection were included. Procalcitonin measurements were obtained the day when the infection was suspected (D0) and at least one time within the 3 previous days (D-3 to D0). Patients with proven infection were compared to those without. The diagnostic value of PCT on D0 was determined through the construction of the corresponding receiver operating characteristic (ROC) curve. In addition, the predictive value of PCT variations preceding the clinical suspicion of infection was assessed.

resultsPCT on D0 was the best predictor of proven infection in this population of ICU patients with a clinical suspicion of infection (AUROCC = 0.80; 95% CI, 0.68-0.91). Thus, a cut-off value of 0.44 ng/mL provides sensitivity and specificity of 65.2% and 83.0%, respectively. Procalcitonin variation between D-1 and D0 was calculated in 45 patients and was also found to be predictive of nosocomial infection (AUROCC = 0.89; 95% CI, 0.79-0.98) with a 100% positive predictive value if the +0.26 ng/mL threshold value was applied. Comparable results were obtained when PCT variation between D-2 and D0, or D-3 and D0 were considered. In contrast, CRP elevation, leukocyte count and fever had a poor predictive value in our population.

conclusionPCT monitoring could be helpful in the early diagnosis of nosocomial infection in the ICU. Both absolute values and variations should be considered and evaluated in further studies.

Indexed as

AgedBiomarkersCalcitoninCalcitonin Gene-Related PeptideCritical IllnessCross InfectionEarly DiagnosisFemaleHospitals, TeachingHumansIntensive Care UnitsMaleMiddle AgedPneumonia, Ventilator-AssociatedPredictive Value of TestsProspective StudiesBiomarkersCALCA protein, humanCalcitoninCalcitonin Gene-Related PeptideProtein Precursors

Identifiers

PMID19386110
PMCPMC2679028
OpenAlexW1974492930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.